102 related articles for article (PubMed ID: 12422752)
1. [MnDPDP--contrast medium with protective effect in acute myocardial infarction].
Hemmingsson A
Lakartidningen; 2002 Oct; 99(40):3955-6. PubMed ID: 12422752
[No Abstract] [Full Text] [Related]
2. Antioxidant activity of mangafodipir is not a new finding.
Karlsson JO
J Hepatol; 2004 May; 40(5):872-3; author reply 873. PubMed ID: 15094242
[No Abstract] [Full Text] [Related]
3. Manganese dipyridoxyl-diphosphate (MnDPDP) as a viability marker in patients with myocardial infarction.
Skjold A; Amundsen BH; Wiseth R; Støylen A; Haraldseth O; Larsson HB; Jynge P
J Magn Reson Imaging; 2007 Sep; 26(3):720-7. PubMed ID: 17729351
[TBL] [Abstract][Full Text] [Related]
4. Relaxation enhancing properties of MnDPDP in human myocardium.
Skjold A; Vangberg TR; Kristoffersen A; Haraldseth O; Jynge P; Larsson HB
J Magn Reson Imaging; 2004 Dec; 20(6):948-52. PubMed ID: 15558550
[TBL] [Abstract][Full Text] [Related]
5. Cardioprotective effects of the MR contrast agent MnDPDP and its metabolite MnPLED upon reperfusion of the ischemic porcine myocardium.
Karlsson JO; Brurok H; Eriksen M; Towart R; Toft KG; Moen O; Engebretsen B; Jynge P; Refsum H
Acta Radiol; 2001 Nov; 42(6):540-7. PubMed ID: 11736698
[TBL] [Abstract][Full Text] [Related]
6. Axon tracing in the adult rat optic nerve and tract after intravitreal injection of MnDPDP using a semiautomatic segmentation technique.
Olsen Ø; Thuen M; Berry M; Kovalev V; Petrou M; Goa PE; Sandvig A; Haraldseth O; Brekken C
J Magn Reson Imaging; 2008 Jan; 27(1):34-42. PubMed ID: 18157895
[TBL] [Abstract][Full Text] [Related]
7. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part I: comparison with pathologic examination.
Kim TH; Yang DH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Gong GY; Lim TH
Invest Radiol; 2005 Jan; 40(1):49-55. PubMed ID: 15597020
[TBL] [Abstract][Full Text] [Related]
8. A new opportunity for MEMRI.
Cloyd R; Vandsburger M; Abisambra JF
Aging (Albany NY); 2017 Aug; 9(8):1855-1856. PubMed ID: 28854148
[No Abstract] [Full Text] [Related]
9. Exploring multifunctional features of necrosis avid contrast agents.
Ni Y; Cresens E; Adriaens P; Dymarkowski S; Bogaert J; Zhang H; Bosmans H; Verbruggen A; Marchal G
Acad Radiol; 2002 Aug; 9 Suppl 2():S488-90. PubMed ID: 12188317
[No Abstract] [Full Text] [Related]
10. Manganese dipyridoxyl diphosphate (MnDPDP)-enhanced magnetic resonance imaging of acute reperfused myocardial injury in a cat model: part II: comparison with cine magnetic resonance imaging.
Yang DH; Kim TH; Choi JW; Kim ST; Yoon JH; Shin JH; Seo JB; Lim TH
Invest Radiol; 2005 Jan; 40(1):56-61. PubMed ID: 15597021
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of MnDPDP and MnCl2 in dogs with acute ischaemic heart failure.
Karlsson JO; Mortensen E; Pedersen HK; Sager G; Refsum H
Acta Radiol; 1997 Jul; 38(4 Pt 2):750-8. PubMed ID: 9245971
[TBL] [Abstract][Full Text] [Related]
12. The magnetic resonance imaging contrast agent mangafodipir exerts antitumor activity via a previously described superoxide dismutase mimetic activity.
Karlsson JO; Brurok H; Towart R; Jynge P
Cancer Res; 2006 Jan; 66(1):598; author reply 598. PubMed ID: 16397277
[No Abstract] [Full Text] [Related]
13. Manganese dipyridoxyl diphosphate: MRI contrast agent with antioxidative and cardioprotective properties?
Brurok H; Ardenkjaer-Larsen JH; Hansson G; Skarra S; Berg K; Karlsson JO; Laursen I; Jynge P
Biochem Biophys Res Commun; 1999 Jan; 254(3):768-72. PubMed ID: 9920816
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and pharmacokinetics of MnDPDP in man.
Toft KG; Hustvedt SO; Grant D; Martinsen I; Gordon PB; Friisk GA; Korsmo AJ; Skotland T
Acta Radiol; 1997 Jul; 38(4 Pt 2):677-89. PubMed ID: 9245963
[TBL] [Abstract][Full Text] [Related]
15. Plasma pharmacokinetics, tissue distribution and excretion of MnDPDP in the rat and dog after intravenous administration.
Hustvedt SO; Grant D; Southon TE; Zech K
Acta Radiol; 1997 Jul; 38(4 Pt 2):690-9. PubMed ID: 9245964
[TBL] [Abstract][Full Text] [Related]
16. Dephosphorylation of MnDPDP and related compounds by acid and alkaline phosphatase.
Toft KG; Myrset AH; Skotland T
J Pharm Biomed Anal; 2001 Jun; 25(3-4):613-8. PubMed ID: 11377042
[TBL] [Abstract][Full Text] [Related]
17. Contrast-enhanced MR imaging in the diagnosis and preservation of cardiac viability.
Smith HJ
Acta Radiol; 2001 Nov; 42(6):539. PubMed ID: 11736697
[No Abstract] [Full Text] [Related]
18. Magnetic resonance imaging of acute reperfused myocardial infarction: intraindividual comparison of ECIII-60 and Gd-DTPA in a swine model.
Jin J; Teng G; Feng Y; Wu Y; Jin Q; Wang Y; Wang Z; Lu Q; Jiang Y; Wang S; Chen F; Marchal G; Ni Y
Cardiovasc Intervent Radiol; 2007; 30(2):248-56. PubMed ID: 17216375
[TBL] [Abstract][Full Text] [Related]
19. NMR relaxation studies with MnDPDP.
Southon TE; Grant D; Bjørnerud A; Moen OM; Spilling B; Martinsen I; Refsum H
Acta Radiol; 1997 Jul; 38(4 Pt 2):708-16. PubMed ID: 9245966
[TBL] [Abstract][Full Text] [Related]
20. MnDPDP: Contrast Agent for Imaging and Protection of Viable Tissue.
Jynge P; Skjold AM; Falkmer U; Andersson RGG; Seland JG; Bruvold M; Blomlie V; Eidsaunet W; Karlsson JOG
Contrast Media Mol Imaging; 2020; 2020():3262835. PubMed ID: 32994754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
